Group One Trading, L.P. Infinity Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.14 - $0.24 $4,009 - $6,874	-28,642 Reduced 66.93%	14,150 $2,000
Q1 2023 May 12, 2023	SELL	$0.16 - $0.74 $7,242 - $33,494	-45,263 Reduced 51.4%	42,792 $6,000
Q4 2022 Feb 09, 2023	SELL	$0.46 - $1.21 $5,174 - $13,610	-11,248 Reduced 11.33%	88,055 $49,000
Q3 2022 Nov 09, 2022	BUY	$0.59 - $1.7 $13,570 - $39,100	23,000 Added 30.14%	99,303 $118,000
Q2 2022 Aug 11, 2022	BUY	$0.49 - $1.2 $4,934 - $12,085	10,071 Added 15.21%	76,303 $48,000
Q1 2022 May 12, 2022	SELL	$0.85 - $2.4 $27,501 - $77,652	-32,355 Reduced 32.82%	66,232 $76,000
Q4 2021 Feb 11, 2022	SELL	$1.86 - $3.36 $111,880 - $202,107	-60,151 Reduced 37.89%	98,587 $222,000
Q3 2021 Nov 12, 2021	BUY	$1.52 - $3.82 $196,412 - $493,616	129,219 Added 437.75%	158,738 $543,000
Q2 2021 Aug 10, 2021	BUY	$2.66 - $3.47 $78,520 - $102,430	29,519 New	29,519 $88,000
Q1 2021 May 12, 2021	SELL	$1.98 - $5.36 $53,768 - $145,556	-27,156 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$1.05 - $2.77 $4,869 - $12,847	-4,638 Reduced 14.59%	27,156 $58,000
Q3 2020 Nov 12, 2020	BUY	$0.82 - $1.34 $18,617 - $30,423	22,704 Added 249.77%	31,794 $37,000
Q1 2020 May 13, 2020	BUY	$0.69 - $1.52 $6,272 - $13,816	9,090 New	9,090 $8,000
Q4 2019 Feb 10, 2020	SELL	$0.88 - $1.29 $1,424 - $2,088	-1,619 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$1.03 - $1.75 $1,159 - $1,970	-1,126 Reduced 41.02%	1,619 $2,000
Q2 2019 Aug 09, 2019	SELL	$1.43 - $1.87 $10,541 - $13,785	-7,372 Reduced 72.87%	2,745 $5,000
Q1 2019 May 13, 2019	BUY	$1.18 - $1.91 $484 - $785	411 Added 4.23%	10,117 $19,000
Q4 2018 Feb 06, 2019	BUY	$1.01 - $2.78 $751 - $2,068	744 Added 8.3%	9,706 $11,000
Q3 2018 Nov 08, 2018	SELL	$1.72 - $2.71 $10,385 - $16,362	-6,038 Reduced 40.25%	8,962 $24,000
Q2 2018 Aug 14, 2018	SELL	$1.72 - $2.26 $39,186 - $51,489	-22,783 Reduced 60.3%	15,000 $29,000
Q1 2018 May 11, 2018	BUY	$1.8 - $2.74 $68,009 - $103,525	37,783 New	37,783 $79,000
Q4 2017 Feb 09, 2018	SELL	$1.22 - $3.73 $18,387 - $56,218	-15,072 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$0.94 - $1.35 $14,167 - $20,347	15,072	15,072 $20,000

Others Institutions Holding INFI

# of Institutions

Shares Held

1.26M

Call Options Held

Put Options Held

View Full List

About INFINITY PHARMACEUTICALS, INC.

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

More about INFI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account